单药治疗-话题@MedSci

#单药治疗#

130篇内容 | 3005人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687770, encodeId=4acb168e77035, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Thyroid：左旋甲状腺素/ L-三碘甲状腺原氨酸与左旋甲状腺素单药治疗成人甲状腺功能减退患者的利弊的系统综述和荟萃分析, objectType=article, longId=219085, objectId=50cc21908555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50cc21908555, replyNumber=0, likeNumber=68, createdTime=2022-01-06, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50cc21908555, moduleTitle=Thyroid：左旋甲状腺素/ L-三碘甲状腺原氨酸与左旋甲状腺素单药治疗成人甲状腺功能减退患者的利弊的系统综述和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50cc21908555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687750, encodeId=eac6168e7501b, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效, objectType=article, longId=207294, objectId=4f3f20e2949c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f3f20e2949c, replyNumber=0, likeNumber=61, createdTime=2021-08-27, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f3f20e2949c, moduleTitle=Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f3f20e2949c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687759, encodeId=d81b168e759e5, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, objectType=article, longId=212913, objectId=5ce1212913f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce1212913f0, replyNumber=0, likeNumber=61, createdTime=2021-09-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce1212913f0, moduleTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ce1212913f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687766, encodeId=1ce6168e7666f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估, objectType=article, longId=217104, objectId=9fe821e104f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fe821e104f9, replyNumber=0, likeNumber=72, createdTime=2022-02-08, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fe821e104f9, moduleTitle=JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fe821e104f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687748, encodeId=ca77168e7480e, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Br J Cancer：倾向匹配生存分析揭示在携带BRAFV600突变的晚期黑色素瘤患者中抗PD-1单药治疗优于BRAF/MEK抑制剂治疗, objectType=article, longId=206683, objectId=000c20668335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=000c20668335, replyNumber=0, likeNumber=90, createdTime=2021-12-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=000c20668335, moduleTitle=Br J Cancer：倾向匹配生存分析揭示在携带BRAFV600突变的晚期黑色素瘤患者中抗PD-1单药治疗优于BRAF/MEK抑制剂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=000c20668335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687752, encodeId=6b0c168e7523d, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Eur Urol：转移性肾细胞癌患者接受Atezolizumab或Sunitinib单药治疗疾病进展后使用Atezolizumab加Bevacizumab的疗效和安全性 , objectType=article, longId=208763, objectId=25ad208e63d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ad208e63d1, replyNumber=0, likeNumber=77, createdTime=2021-06-05, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ad208e63d1, moduleTitle=Eur Urol：转移性肾细胞癌患者接受Atezolizumab或Sunitinib单药治疗疾病进展后使用Atezolizumab加Bevacizumab的疗效和安全性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ad208e63d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687749, encodeId=cb15168e749f0, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=ASCO GU 2021：固定剂量的Durvalumab单药治疗尿道肿瘤具有良好的安全性（STRONG研究）, objectType=article, longId=207176, objectId=9c2020e176f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2020e176f1, replyNumber=0, likeNumber=68, createdTime=2021-04-24, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2020e176f1, moduleTitle=ASCO GU 2021：固定剂量的Durvalumab单药治疗尿道肿瘤具有良好的安全性（STRONG研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2020e176f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687746, encodeId=1050168e746e7, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验, objectType=article, longId=204612, objectId=b76e204612db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b76e204612db, replyNumber=0, likeNumber=58, createdTime=2021-08-06, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b76e204612db, moduleTitle=Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b76e204612db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687747, encodeId=44bf168e7473d, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=一项在真实世界中的研究：格列齐特缓释片和西格列汀作为二甲双胍单药治疗控制不佳的2型糖尿病患者二线治疗的疗效比较, objectType=article, longId=205833, objectId=25a8205833ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25a8205833ad, replyNumber=0, likeNumber=36, createdTime=2022-01-01, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25a8205833ad, moduleTitle=一项在真实世界中的研究：格列齐特缓释片和西格列汀作为二甲双胍单药治疗控制不佳的2型糖尿病患者二线治疗的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25a8205833ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687756, encodeId=ba68168e75617, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet：每日1次Upadacitinib单药治疗可显著改善中重度特应性皮炎患者临床症状, objectType=article, longId=211663, objectId=c26d2116637e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c26d2116637e, replyNumber=0, likeNumber=72, createdTime=2021-06-30, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c26d2116637e, moduleTitle=Lancet：每日1次Upadacitinib单药治疗可显著改善中重度特应性皮炎患者临床症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c26d2116637e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687755, encodeId=6ce9168e75535, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JAHA：导管主动脉瓣植入术后阿司匹林单药治疗与双重抗血小板治疗比较, objectType=article, longId=210084, objectId=7a442100846b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a442100846b, replyNumber=0, likeNumber=93, createdTime=2021-10-15, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a442100846b, moduleTitle=JAHA：导管主动脉瓣植入术后阿司匹林单药治疗与双重抗血小板治疗比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a442100846b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687754, encodeId=987a168e754c4, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet respirat med：派姆单抗单药治疗晚期间皮瘤的疗效分析, objectType=article, longId=209709, objectId=6bf2209e091f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf2209e091f, replyNumber=0, likeNumber=71, createdTime=2021-12-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf2209e091f, moduleTitle=Lancet respirat med：派姆单抗单药治疗晚期间皮瘤的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bf2209e091f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687753, encodeId=a9b3168e753b0, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Diabetes Care：Imeglimin单药治疗2型糖尿病的降低效果, objectType=article, longId=208785, objectId=649d208e85bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649d208e85bd, replyNumber=0, likeNumber=76, createdTime=2021-08-10, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649d208e85bd, moduleTitle=Diabetes Care：Imeglimin单药治疗2型糖尿病的降低效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649d208e85bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687742, encodeId=9c9a168e74268, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切, objectType=article, longId=196105, objectId=041919610548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=041919610548, replyNumber=0, likeNumber=78, createdTime=2020-12-03, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=041919610548, moduleTitle=III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=041919610548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687745, encodeId=8933168e7454c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验, objectType=article, longId=202468, objectId=9f3d20246844, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f3d20246844, replyNumber=0, likeNumber=79, createdTime=2021-02-02, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f3d20246844, moduleTitle=TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f3d20246844)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687751, encodeId=b15e168e75186, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究, objectType=article, longId=207391, objectId=875f20e391ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875f20e391ec, replyNumber=0, likeNumber=69, createdTime=2021-08-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875f20e391ec, moduleTitle=Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875f20e391ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687744, encodeId=5422168e7448c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较 , objectType=article, longId=198335, objectId=666e198335c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=666e198335c9, replyNumber=0, likeNumber=75, createdTime=2020-11-16, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=666e198335c9, moduleTitle=Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=666e198335c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687739, encodeId=f30b168e7391b, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较, objectType=article, longId=192087, objectId=6d0019208efd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d0019208efd, replyNumber=0, likeNumber=73, createdTime=2020-09-11, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d0019208efd, moduleTitle=J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d0019208efd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687743, encodeId=327b168e7436e, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析, objectType=article, longId=196280, objectId=fe3c1962807f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3c1962807f, replyNumber=0, likeNumber=73, createdTime=2020-10-04, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3c1962807f, moduleTitle=J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3c1962807f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687740, encodeId=7498168e74021, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle= J Clin Hypertens: 男性、年轻、吸烟、单药治疗影响高血压控制！王继光等对36.4万人的研究, objectType=article, longId=193001, objectId=ecbe193001ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecbe193001ca, replyNumber=0, likeNumber=86, createdTime=2020-08-02, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecbe193001ca, moduleTitle= J Clin Hypertens: 男性、年轻、吸烟、单药治疗影响高血压控制！王继光等对36.4万人的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecbe193001ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

单药治疗

2020-05-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Thyroid：左旋甲状腺素/ L-三碘甲状腺原氨酸与左旋甲状腺素单药治疗成人甲状腺功能减退患者的利弊的系统综述和荟萃分析

2022-01-06

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：派姆单抗单药治疗PD-L1联合阳性评分≥10的胃/胃食管交界癌的疗效

2021-08-27

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大

2021-09-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JASN：甲强龙静脉注射后使用他克莫司单药治疗成人肾病综合征的疗效评估

2022-02-08

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Br J Cancer：倾向匹配生存分析揭示在携带BRAFV600突变的晚期黑色素瘤患者中抗PD-1单药治疗优于BRAF/MEK抑制剂治疗

2021-12-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Eur Urol：转移性肾细胞癌患者接受Atezolizumab或Sunitinib单药治疗疾病进展后使用Atezolizumab加Bevacizumab的疗效和安全性

2021-06-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

ASCO GU 2021：固定剂量的Durvalumab单药治疗尿道肿瘤具有良好的安全性（STRONG研究）

2021-04-24

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验

2021-08-06

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

一项在真实世界中的研究：格列齐特缓释片和西格列汀作为二甲双胍单药治疗控制不佳的2型糖尿病患者二线治疗的疗效比较

2022-01-01

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet：每日1次Upadacitinib单药治疗可显著改善中重度特应性皮炎患者临床症状

2021-06-30

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JAHA：导管主动脉瓣植入术后阿司匹林单药治疗与双重抗血小板治疗比较

2021-10-15

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet respirat med：派姆单抗单药治疗晚期间皮瘤的疗效分析

2021-12-26

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Diabetes Care：Imeglimin单药治疗2型糖尿病的降低效果

2021-08-10

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

III期临床试验证明：Dorzagliatin单药治疗2型糖尿病疗效确切

2020-12-03

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

TCT 2020丨TICO-STEMI研究：在STEMI患者中应用替格瑞洛单药治疗与替格瑞洛联合阿司匹林治疗的随机临床试验

2021-02-02

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究

2021-08-26

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Sci Rep：来氟米特单药治疗类风湿性关节炎与联合疗法的比较

2020-11-16

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

J Rheumatol：银屑病关节炎中TNFi单药治疗与联合治疗的比较

2020-09-11

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析

2020-10-04

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

J Clin Hypertens: 男性、年轻、吸烟、单药治疗影响高血压控制！王继光等对36.4万人的研究

2020-08-02

科室
- - 订阅+
  - 更多科室
工具
服务